{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:35:15Z","timestamp":1781022915145,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Major Project","award":["2015ZX09102022"],"award-info":[{"award-number":["2015ZX09102022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00705-017-3436-8","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T11:58:20Z","timestamp":1496923100000},"page":"2847-2853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication"],"prefix":"10.1007","volume":"162","author":[{"given":"Lei","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuchun","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"3436_CR1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"RS Lanciotti","year":"2008","unstructured":"Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ et al (2008) Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232\u20131239","journal-title":"Emerg Infect Dis"},{"key":"3436_CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick GW, Kitchen SF, Haddow AJ (1952) Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46:509\u2013520","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3436_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES2014.19.41.20929","volume":"19","author":"A Roth","year":"2014","unstructured":"Roth A, Mercier A, Lepers C, Hoy D, Duituturaga S et al (2014) Concurrent outbreaks of dengue, chikungunya and Zika virus infections\u2014an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012\u20132014. Eurosurveillance 19:2\u20139","journal-title":"Eurosurveillance"},{"key":"3436_CR4","unstructured":"World Health Organization, Zika situation report (2017) \n                        http:\/\/www.who.int\/emergencies\/zika-virus\/situation-report\/05-january-2017\/en\/\n                        \n                    . Accessed 17 Jan 22"},{"key":"3436_CR5","doi-asserted-by":"crossref","first-page":"e0004530","DOI":"10.1371\/journal.pntd.0004530","volume":"10","author":"RW Malone","year":"2016","unstructured":"Malone RW, Homan J, Callahan MV, Glasspool-Malone J, Damodaran L et al (2016) Zika virus: medical countermeasure development challenges. PLoS Negl Trop Dis 10:e0004530","journal-title":"PLoS Negl Trop Dis"},{"key":"3436_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000452950","volume":"59","author":"MI Faizan","year":"2017","unstructured":"Faizan MI, Abdullah M, Ali S, Naqvi IH, Ahmed A et al (2017) Zika virus-induced microcephaly and its possible molecular mechanism. Intervirology 59:152\u2013158","journal-title":"Intervirology"},{"key":"3436_CR7","first-page":"59","volume":"65","author":"L Schuler-Faccini","year":"2016","unstructured":"Schuler-Faccini L, Ribeiro EM, Feitosa IML, Horovitz DDG, Cavalcanti DP et al (2016) Possible association between Zika virus infection and microcephaly\u2014Brazil, 2015. MMWR 65:59\u201362","journal-title":"MMWR"},{"key":"3436_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/1560-7917.ES2014.19.9.20720","volume":"19","author":"E Oehler","year":"2014","unstructured":"Oehler E, Watrin L, Larre P, Leparc-Goffart I, Last\u00e8re S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F (2014) Zika virus infection complicated by Guillain-Barr\u00e9 syndrome\u2014case report, French Polynesia. Euro Surveill 19:3","journal-title":"Euro Surveill"},{"key":"3436_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS et al (2016) Rapid development of a DNA vaccine for Zika virus. Science 354:237\u2013240","journal-title":"Science"},{"key":"3436_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.11.020","volume":"137","author":"K Hercik","year":"2017","unstructured":"Hercik K, Kozak J, Sala M, Dejmek M, Hrebabecky H et al (2017) Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase. Antiviral Res 137:131\u2013133","journal-title":"Antiviral Res"},{"key":"3436_CR11","doi-asserted-by":"publisher","unstructured":"Coutard B, Barral K, Lichi\u00e8re J, Selisko B, Martin B et al (2017) Zika virus methyltransferase: structure and functions for drug design perspectives. J Virol 91. doi:\n                        10.1128\/JVI.02202-16","DOI":"10.1128\/JVI.02202-16"},{"key":"3436_CR12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","volume":"51","author":"RW Sidwell","year":"2007","unstructured":"Sidwell RW, Barnard DL, Day CW, Smee DF, Bailey KW et al (2007) Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother 51:845\u2013851","journal-title":"Antimicrob Agents Chemother"},{"key":"3436_CR13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","volume":"6","author":"S Crotty","year":"2000","unstructured":"Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY et al (2000) The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 6:1375\u20131379","journal-title":"Nat Med"},{"key":"3436_CR14","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1086\/656717","volume":"202","author":"DC Quenelle","year":"2010","unstructured":"Quenelle DC, Lampert B, Collins DJ, Rice TL, Painter GR et al (2010) Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies. J Infect Dis 202:1492\u20131499","journal-title":"J Infect Dis"},{"key":"3436_CR15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","volume":"12","author":"DF Florescu","year":"2014","unstructured":"Florescu DF, Keck MA (2014) Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert Rev Anti Infect Ther 12:1171\u20131178","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3436_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","volume":"61","author":"DF Florescu","year":"2015","unstructured":"Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U et al (2015) Administration of brincidofovir and convalescent plasma in a patient with ebola virus disease. Clin Infect Dis 61:969\u2013973","journal-title":"Clin Infect Dis"},{"key":"3436_CR17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","volume":"46","author":"Y Furuta","year":"2002","unstructured":"Furuta Y, Takahashi K, Fukuda Y, Kuno M, Kamiyama T et al (2002) In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother 46:977\u2013981","journal-title":"Antimicrob Agents Chemother"},{"key":"3436_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","volume":"49","author":"Y Furuta","year":"2005","unstructured":"Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S et al (2005) Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother 49:981\u2013986","journal-title":"Antimicrob Agents Chemother"},{"key":"3436_CR19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01739-09","volume":"54","author":"K Sleeman","year":"2010","unstructured":"Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI et al (2010) In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother 54:2517\u20132524","journal-title":"Antimicrob Agents Chemother"},{"key":"3436_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","volume":"105","author":"L Oestereich","year":"2014","unstructured":"Oestereich L, Ludtke A, Wurr S, Rieger T, Munoz-Fontela C et al (2014) Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res 105:17\u201321","journal-title":"Antiviral Res"},{"key":"3436_CR21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Y Furuta","year":"2013","unstructured":"Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF et al (2013) Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 100:446\u2013454","journal-title":"Antiviral Res"},{"key":"3436_CR22","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","volume":"3","author":"YQ Deng","year":"2016","unstructured":"Deng YQ, Zhang NN, Li CF, Tian M, Hao JN et al (2016) Adenosine analog NITD008 is a potent inhibitor of Zika virus. Open Forum Infect Dis 3:ofw175","journal-title":"Open Forum Infect Dis"},{"key":"3436_CR23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11427-016-5043-4","volume":"59","author":"YQ Deng","year":"2016","unstructured":"Deng YQ, Zhao H, Li XF, Zhang NN, Liu ZY et al (2016) Isolation, identification and genomic characterization of the Asian lineage Zika virus imported to China. Sci China Life Sci 59:428\u2013430","journal-title":"Sci China Life Sci"},{"key":"3436_CR24","first-page":"83","volume-title":"Virus culture: a practical approach","author":"AJ Cann","year":"1999","unstructured":"Cann AJ (1999) Virus culture: a practical approach. Oxford University Press, Oxford, pp 83\u201384"},{"key":"3436_CR25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc 3:1125\u20131131","journal-title":"Nat Protoc"},{"key":"3436_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","volume":"214","author":"L Eyer","year":"2016","unstructured":"Eyer L, Nencka R, Huvarova I, Palus M, Joao Alves M et al (2016) Nucleoside inhibitors of Zika virus. J Infect Dis 214:707\u2013711","journal-title":"J Infect Dis"},{"key":"3436_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-017-3345-x","author":"K Hercik","year":"2017","unstructured":"Hercik K, Brynda J, Nencka R, Boura E (2017) Structural basis of Zika virus methyltransferase inhibition by sinefungin. Arch Virol. doi:\n                        10.1007\/s00705-017-3345-x","journal-title":"Arch Virol"},{"key":"3436_CR28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/2040206616653873","volume":"24","author":"BD Cox","year":"2015","unstructured":"Cox BD, Stanton RA, Schinazi RF (2015) Predicting Zika virus structural biology: challenges and opportunities for intervention. Antivir Chem Chemother 24:118\u2013126","journal-title":"Antivir Chem Chemother"},{"key":"3436_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","volume":"53","author":"JG Julander","year":"2009","unstructured":"Julander JG, Shafer K, Smee DF, Morrey JD, Furuta Y (2009) Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrob Agents Chemother 53:202\u2013209","journal-title":"Antimicrob Agents Chemother"},{"key":"3436_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.antiviral.2008.07.009","volume":"80","author":"JD Morrey","year":"2008","unstructured":"Morrey JD, Taro BS, Siddharthan V, Wang H, Smee DF et al (2008) Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res 80:377\u2013379","journal-title":"Antiviral Res"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-017-3436-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3436-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3436-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,20]],"date-time":"2017-08-20T07:39:52Z","timestamp":1503214792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-017-3436-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3436"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3436-8","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}